BR9909476A - Novos tratamentos para distúrbios nervosos - Google Patents

Novos tratamentos para distúrbios nervosos

Info

Publication number
BR9909476A
BR9909476A BR9909476-2A BR9909476A BR9909476A BR 9909476 A BR9909476 A BR 9909476A BR 9909476 A BR9909476 A BR 9909476A BR 9909476 A BR9909476 A BR 9909476A
Authority
BR
Brazil
Prior art keywords
new treatments
nervous disorders
disease
reboxetine
ocd
Prior art date
Application number
BR9909476-2A
Other languages
English (en)
Inventor
Adriana Dubini
John Michael Mccall
Duncan Paul Taylor
Philip F Von Voigtlander
Erik Ho Fong Wong
Original Assignee
Pharmacia & Upjohn Spa
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa, Upjohn Co filed Critical Pharmacia & Upjohn Spa
Publication of BR9909476A publication Critical patent/BR9909476A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

<B>NOVOS TRATAMENTOS PARA DISTúRBIOS NERVOSOS<D> Esta aplicação de patente descreve o tratamento de Doença compulsiva Obsessiva (OCD), e Doença do Pânico (PD), compreendendo a administração de uma dose não tóxica, terapeuticamente eficaz de Reboxetine e derivados e ou sais farmaceuticamente aceitáveis deste a um paciente.
BR9909476-2A 1998-04-13 1999-04-02 Novos tratamentos para distúrbios nervosos BR9909476A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11
PCT/US1999/004288 WO1999052518A2 (en) 1998-04-13 1999-04-02 New treatments for nervous disorders

Publications (1)

Publication Number Publication Date
BR9909476A true BR9909476A (pt) 2000-12-19

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909476-2A BR9909476A (pt) 1998-04-13 1999-04-02 Novos tratamentos para distúrbios nervosos

Country Status (25)

Country Link
US (1) US6391876B1 (pt)
EP (1) EP1071418B1 (pt)
JP (1) JP2002511408A (pt)
KR (1) KR100555279B1 (pt)
CN (1) CN1197569C (pt)
AT (1) ATE277617T1 (pt)
AU (1) AU755612B2 (pt)
BR (1) BR9909476A (pt)
CA (1) CA2320722A1 (pt)
DE (1) DE69920679T2 (pt)
DK (1) DK1071418T3 (pt)
EA (1) EA003546B1 (pt)
ES (1) ES2228035T3 (pt)
HU (1) HUP0101748A3 (pt)
IL (1) IL138887A0 (pt)
IT (1) IT1305322B1 (pt)
NO (1) NO20005131L (pt)
NZ (1) NZ507693A (pt)
PL (1) PL194039B1 (pt)
PT (1) PT1071418E (pt)
SI (1) SI1071418T1 (pt)
SK (1) SK14482000A3 (pt)
TR (1) TR200002970T2 (pt)
WO (1) WO1999052518A2 (pt)
ZA (1) ZA200004480B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
US6465458B1 (en) 1999-07-01 2002-10-15 Pharmacia & Upjohn Company Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor
SI1196172T1 (sl) * 1999-07-01 2006-06-30 Pharmacia & Upjohn Co Llc (S,S)-reboksetin za zdravljenje kronicne bolecine
BR0115301A (pt) * 2000-11-15 2004-12-14 Lilly Co Eli Uso de um inibidor seletivo da recaptação de norepinefrina
CN1662511B (zh) * 2002-06-17 2010-06-09 辉瑞意大利公司 瑞波西汀的药物盐
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
AU9692898A (en) 1997-10-17 1999-05-10 Eli Lilly And Company Potentiation of pharmaceuticals

Also Published As

Publication number Publication date
NO20005131D0 (no) 2000-10-12
CA2320722A1 (en) 1999-10-21
HUP0101748A3 (en) 2001-12-28
ITMI980870A1 (it) 1999-10-23
EP1071418B1 (en) 2004-09-29
CN1197569C (zh) 2005-04-20
DK1071418T3 (da) 2005-01-03
EA200001058A1 (ru) 2001-04-23
NO20005131L (no) 2000-10-12
DE69920679D1 (de) 2004-11-04
SK14482000A3 (sk) 2001-08-06
DE69920679T2 (de) 2006-03-02
CN1293569A (zh) 2001-05-02
WO1999052518A2 (en) 1999-10-21
PL194039B1 (pl) 2007-04-30
TR200002970T2 (tr) 2001-01-22
AU755612B2 (en) 2002-12-19
KR100555279B1 (ko) 2006-03-03
US6391876B1 (en) 2002-05-21
HUP0101748A2 (hu) 2001-11-28
IT1305322B1 (it) 2001-05-04
EA003546B1 (ru) 2003-06-26
ATE277617T1 (de) 2004-10-15
IL138887A0 (en) 2001-11-25
JP2002511408A (ja) 2002-04-16
EP1071418A2 (en) 2001-01-31
SI1071418T1 (en) 2005-04-30
PL346294A1 (en) 2002-01-28
ES2228035T3 (es) 2005-04-01
AU3635199A (en) 1999-11-01
NZ507693A (en) 2003-08-29
WO1999052518A3 (en) 1999-12-02
PT1071418E (pt) 2004-12-31
KR20010042641A (ko) 2001-05-25
ZA200004480B (en) 2002-04-24

Similar Documents

Publication Publication Date Title
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
BR0013478A (pt) Combinação sinergìstica
EA200701175A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
BR0307050A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
TW200607510A (en) Use of optically pure (s.s)-reboxetine in the manufacture of a medicament for the treatment or prevention of fibromyalgia or another somatoform disorder
BR0008323A (pt) Derivado de gabapentina para a prevenção e o tratamento de dor visceral
EE05315B1 (et) Dapoksetiini v?i selle farmatseutiliselt vastuv?etava soola kasutamine ravimi valmistamiseks, mis on ette n„htud imetajal esineva seksuaalse funktsioonih„ire ravimiseks v?i m?jutamiseks
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
BRPI0414347A (pt) associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
ATE451934T1 (de) Pharmazeutische zusammensetzung zur behandlung von rhinitiden
TR200200014T2 (tr) Nörotik düzensizliklerin tedavisi.
BR9909476A (pt) Novos tratamentos para distúrbios nervosos
BR9909478A (pt) Novos tratamentos para vários distúrbios do sistema nervoso
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
TW200420290A (en) Methods for the treatment, prevention and management of macular degeneration
BR9909917A (pt) Novos usos e combinações de cabergoline e pramipexole
BR0316451A (pt) Combinação sinergìstica compreendendo roflumilast e formoterol
BR0208488A (pt) Agonistas de kapa-opiato para o tratamento de doenças da bexiga
WO2005046594A3 (en) Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders
BR0009704A (pt) Utilização do osanetant para a preparação de medicamentos úteis no tratamento das perturbações do humor
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
EP1632235A3 (en) Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/5375, A61P 25/22

Ipc: A61K 31/5375 (2007.10), A61P 25/22 (2007.10)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.